Literature DB >> 14617353

HIV-1 egress is gated through late endosomal membranes.

Sascha Nydegger1, Michelangelo Foti, Aaron Derdowski, Paul Spearman, Markus Thali.   

Abstract

HIV-1 buds from the surface of activated T lymphocytes. In macrophages, however, newly formed HIV-1 particles amass in the lumen of an intracellular compartment. Here, we demonstrate by live-cell imaging techniques, by immunocytochemistry and by immuno-electron microscopy that HIV-1 structural proteins, particularly the internal structural protein Gag, accumulate at membranes of the late endocytic compartment in a variety of cell types and not just in monocyte/macrophage-derived cells. Recent biochemical and genetic studies have implicated components of the mammalian vacuolar protein sorting pathway in retroviral budding. Together with those observations, our study suggests that HIV-1 morphogenesis is thoroughly rooted in the endosomal system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617353     DOI: 10.1046/j.1600-0854.2003.00145.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  102 in total

1.  Identification of cellular proteins required for replication of human immunodeficiency virus type 1.

Authors:  Natallia Dziuba; Monique R Ferguson; William A O'Brien; Anthony Sanchez; Andrew J Prussia; Natalie J McDonald; Brian M Friedrich; Guangyu Li; Michael W Shaw; Jinsong Sheng; Thomas W Hodge; Donald H Rubin; James L Murray
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-20       Impact factor: 2.205

2.  Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.

Authors:  Virginie Sandrin; Delphine Muriaux; Jean-Luc Darlix; François-Loïc Cosset
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components.

Authors:  Dimitry N Krementsov; Patrice Rassam; Emmanuel Margeat; Nathan H Roy; Jürgen Schneider-Schaulies; Pierre-Emmanuel Milhiet; Markus Thali
Journal:  Traffic       Date:  2010-11       Impact factor: 6.215

4.  Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.

Authors:  Andrés Finzi; Alexandre Brunet; Yong Xiao; Jacques Thibodeau; Eric A Cohen
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.

Authors:  Elena Chertova; Oleg Chertov; Lori V Coren; James D Roser; Charles M Trubey; Julian W Bess; Raymond C Sowder; Eugene Barsov; Brian L Hood; Robert J Fisher; Kunio Nagashima; Thomas P Conrads; Timothy D Veenstra; Jeffrey D Lifson; David E Ott
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101.

Authors:  Gisselle Medina; Yongjun Zhang; Yi Tang; Eva Gottwein; Marcy L Vana; Fadila Bouamr; Jonathan Leis; Carol A Carter
Journal:  Traffic       Date:  2005-10       Impact factor: 6.215

7.  Analysis of human immunodeficiency virus matrix domain replacements.

Authors:  Isabel Scholz; Amelia Still; Tenzin Choesang Dhenub; Kelsey Coday; Mike Webb; Eric Barklis
Journal:  Virology       Date:  2007-11-08       Impact factor: 3.616

8.  Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment.

Authors:  Anjali Joshi; Sherimay D Ablan; Ferri Soheilian; Kunio Nagashima; Eric O Freed
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 9.  The roles of tetraspanins in HIV-1 replication.

Authors:  Markus Thali
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 10.  Imaging of HIV/host protein interactions.

Authors:  Cindy M Danielson; Thomas J Hope
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.